Supplementary Figure 5 from Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay
Nakamura Y., Tsukada Y., Matsuhashi N., Murano T., Shiozawa M., Takahashi Y., Oki E., Goto M., Kagawa Y., Kanazawa A., Ohta T., Ouchi A., Bando H., Uchigata H., Notake C., Ikematsu H., Yoshino T.
<p>Supplementary Figure 5. RFI based on ctDNA detection at each surveillance time point in patients with stage II or higher CRC.</p>